Antisense oligonucleotide-mediated silencing of PNPLA3 reduces inflammation and fibrosis in PNPLA3 I148M knock-in mice model of NASH [192]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.